Literature DB >> 15887128

American Gastroenterological Association medical position statement: Role of the gastroenterologist in the management of esophageal carcinoma.

Kenneth K Wang1, Michel Wongkeesong, Navtej S Buttar.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15887128     DOI： 10.1053/j.gastro.2005.03.076

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  17 in total

1.  Esophageal adenocarcinoma.

Authors:  Kenneth K Wang
Journal:  Clin Gastroenterol Hepatol       Date:  2006-09-18       Impact factor: 11.382

2.  Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans.

Authors:  Joel H Rubenstein; Amnon Sonnenberg; Jennifer Davis; Laurence McMahon; John M Inadomi
Journal:  Gastrointest Endosc       Date:  2008-06-11       Impact factor: 9.427

3.  The essence of management of Barrett's esophagus.

Authors:  Kenneth K Wang
Journal:  Gastrointest Endosc       Date:  2013-11       Impact factor: 9.427

4.  Barrett's Esophagus: Diagnosis, Screening, Surveillance, and Controversies.

Authors:  Rajvinder Singh; Krish Ragunath; Janusz Jankowski
Journal:  Gut Liver       Date:  2007-12-31       Impact factor: 4.519

5.  Inter-endoscopist agreement in diagnosis of Barrett's oesophagus.

Authors:  Glen A Doherty; Danny G Cheriyan; Jan E Leyden; John F O'Dowd; Frank E Murray; Stephen E Patchett
Journal:  Frontline Gastroenterol       Date:  2011-03-20

6.  Overutilization of endoscopic surveillance in nondysplastic Barrett's esophagus: a multicenter study.

Authors:  Seth D Crockett; Isaac M Lipkus; Stephanie D Bright; Richard E Sampliner; Kenneth K Wang; Vikram Boolchand; Lori S Lutzke; Nicholas J Shaheen
Journal:  Gastrointest Endosc       Date:  2011-11-17       Impact factor: 9.427

7.  Barrett's esophagus on repeat endoscopy: should we look more than once?

Authors:  Sarah Rodriguez; Nora Mattek; David Lieberman; Brian Fennerty; Glenn Eisen
Journal:  Am J Gastroenterol       Date:  2008-06-28       Impact factor: 10.864

Review 8.  A cost-utility analysis of ablative therapy for Barrett's esophagus.

Authors:  John M Inadomi; Ma Somsouk; Ryan D Madanick; Jennifer P Thomas; Nicholas J Shaheen
Journal:  Gastroenterology       Date:  2009-03-06       Impact factor: 22.682

9.  Next-generation sequencing of endoscopic biopsies identifies ARID1A as a tumor-suppressor gene in Barrett's esophagus.

Authors:  M M Streppel; S Lata; M DelaBastide; E A Montgomery; J S Wang; M I Canto; A M Macgregor-Das; S Pai; F H M Morsink; G J Offerhaus; E Antoniou; A Maitra; W R McCombie
Journal:  Oncogene       Date:  2013-01-14       Impact factor: 9.867

10.  ERCC1 RNA expression in peripheral blood predicts minor histopathological response to neoadjuvant radio-chemotherapy in patients with locally advanced cancer of the esophagus.

Authors:  Jan Brabender; Daniel Vallböhmer; Peter Grimminger; Andreas C Hoffmann; Frederike Ling; Georg Lurje; Elfriede Bollschweiler; Paul M Schneider; Arnulf H Hölscher; Ralf Metzger
Journal:  J Gastrointest Surg       Date:  2008-09-03       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.